SOPHiA Genetics is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. Co. is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. Co.'s customers generally perform testing on their own samples, retain custody of both their sample and data, and use Co.'s SOPHiA platform to analyze the pseudonymized data. The SOPHiA DDM Platform and related solutions, products and services are used by more than 750 hospital, laboratory and biopharma institutions globally. The SOPH average annual return since 2021 is shown above.
The Average Annual Return on the SOPH average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SOPH average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SOPH average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|